USPTO 2015–2025 USPTO PatentsView US Corporation

Azena Medical, LLC

USPTO PatentsView assignee record - 9 granted patents across 7 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Azena ranks #28,193 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 7 technology areas.

#28,193
of 49,997 US assignees by volume
20th percentile
by Innovation Score (26.4/100)
9.6
avg claims per patent
+250%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R28193 · US Corporation #28,193 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 9 grants
  • MID-PACK #28,193/49,997
  • PHOTO-FINISH Avatier
  • CPC-NARROW A61B · 7 areas
  • INNOV-THIN 26.4/100
  • CLAIMS-PAR 9.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +250% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Avatier Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Azena’s 26.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Azena

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Azena's Innovation Score is 26.4/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Azena?

Each dot is one of Azena’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Azena’s own 9.6 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Azena vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 8.98.999.1 510152025 Granted patents (volume) Avg claims / patent Avatier Corporation - 9, 14.11AvatierAvery Design Systems, Inc. - 9, 14.78Avery Design Syst…Axiado Corporation - 9, 19.78AxiadoAxioMx, Inc. - 9, 16.89AxiomxB DOT Medical Inc. - 9, 6.44B DOT MedicalB.R.A.I.N. Biotechnology Research and Information Network AG - 9, 18.44B R A I N Biotech…Babington Technology, Inc. - 9, 16Babington Technol…Babolat VS - 9, 12.22Babolat VSAzena Medical, LLC - 9, 9.56Azena Medical
Azena vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Azena's grants concentrate

Azena Medical, LLC is a focused PatentsView assignee: 7 CPC subclasses with 22.2% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2021. By volume, Azena sits between Avatier Corporation and Babolat VS.

Azena's three-year grant acceleration

Azena Medical, LLC shows 3 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Azena's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Azena holds 9 patents at rank #28,193, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Azena

By rank, the assignees closest to #28,193 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Azena's primary technology class.

Azena's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 20th percentile higher than 20% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20192020202120222024 2
USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Azena Medical, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 2 22.2%
2020 3 33.3%
2021 1 11.1%
2022 1 11.1%
2024 2 22.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Azena Medical, LLC's patent record in context - here's where to go next.

  • Azena Medical, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 22.2% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #28,193 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Azena Medical, LLC against Avatier Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 26.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.